MDT

100.13

+4.12%↑

136.65

-1.01%↓

VEEV

220.54

-0.41%↓

HQY

84.37

-0.86%↓

NEOG

9.44

+2.83%↑

MDT

100.13

+4.12%↑

136.65

-1.01%↓

VEEV

220.54

-0.41%↓

HQY

84.37

-0.86%↓

NEOG

9.44

+2.83%↑

MDT

100.13

+4.12%↑

136.65

-1.01%↓

VEEV

220.54

-0.41%↓

HQY

84.37

-0.86%↓

NEOG

9.44

+2.83%↑

MDT

100.13

+4.12%↑

136.65

-1.01%↓

VEEV

220.54

-0.41%↓

HQY

84.37

-0.86%↓

NEOG

9.44

+2.83%↑

MDT

100.13

+4.12%↑

136.65

-1.01%↓

VEEV

220.54

-0.41%↓

HQY

84.37

-0.86%↓

NEOG

9.44

+2.83%↑

Strona główna・Stock List・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Closed

SectorHealthcare

30.23 0.77

Buy Sell

Overview

Share price change

24h

Current

Min

29.54

Max

31.2

Key metrics
By Trading Economics
Income	-1.8M -21M
Sales	4.1M 83M
Profit margin	-25.695
Employees	756
EBITDA	4.8M -19M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+64.12% upside

Dividends
By Dow Jones
Next Earnings	24 lut 2026

Market Stats
By TradingEconomics
Market Cap	-222M 1.7B
Previous open	29.46
Previous close	30.23

News Sentiment

By Acuity

50%

159 / 361 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

52.655 / 56.31 Support & Resistance

PROCEPT BioRobotics Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 sty 2026, 23:43 UTC

Market Talk

Gold Consolidates; May Face Technical Correction -- Market Talk

20 sty 2026, 23:42 UTC

Market Talk

Nikkei May Fall Amid Concerns Over U.S.-Europe Trade Relations -- Market Talk

20 sty 2026, 23:41 UTC

Earnings

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- 2nd Update

20 sty 2026, 23:29 UTC

Market Talk

RBA Rate Hike in February Would Be a Painful One -- Market Talk

20 sty 2026, 23:26 UTC

Market Talk

Global Equities Roundup: Market Talk

20 sty 2026, 23:26 UTC

Market Talk

James Hardie Appeals More as Reece's U.S. Strategy Comes Under Scrutiny -- Market Talk

20 sty 2026, 22:45 UTC

Acquisitions, Mergers, Takeovers

ACCC: Ampol-EG Deal Is First Assessment Subject to Phase 2 Review Under New Merger Control Regime

20 sty 2026, 22:45 UTC

Acquisitions, Mergers, Takeovers

ACCC Seeks Submissions in Response to Phase 2 Notice by February 4

20 sty 2026, 22:44 UTC

Acquisitions, Mergers, Takeovers

ACCC: Ampol's Offer to Sell 19 Retail Fuel Sites Doesn't Adequately Address Issues

20 sty 2026, 22:44 UTC

Acquisitions, Mergers, Takeovers

ACCC Identifies 115 EG Sites Where Deal Could Substantially Lessen Competition

20 sty 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

ACCC Says Deal Could Substantially Lessen Competition in Retail Supply of Petrol, Diesel in Several Markets in Australia

20 sty 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

Ampol's Acquisition of EG Australia to Undergo In-Depth Review by Competition Regulator

20 sty 2026, 22:27 UTC

Acquisitions, Mergers, Takeovers

Netflix Plans to Roll Out New Mobile User Interface Later This Year, Co-CEO Says

20 sty 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

Netflix Co-CEO Sees Uptick in Engagement for TV-Based Games

20 sty 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Netflix Would Keep 45-Day Theater Release Window for Warner Bros. Films, Co-CEO Says

20 sty 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Netflix Excited to Strengthen Warner Bros.'s Theatrical-Distribution Business, Co-CEO Says

20 sty 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Netflix Pleased With Early Results for Podcasts, Co-CEO Says

20 sty 2026, 22:18 UTC

Earnings

Netflix Stock Is Falling. This Is Overshadowing the Streamer's Earnings Beat. -- Barrons.com

20 sty 2026, 22:17 UTC

Acquisitions, Mergers, Takeovers

Netflix's Live Events Are Boosting Retention, Co-CEO Says

20 sty 2026, 22:16 UTC

Acquisitions, Mergers, Takeovers

Netflix Remains 'Very Excited' About Live-Events Offering, Co-CEO Says

20 sty 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Netflix's Proposed Deal for Warner Bros. Would Protect, Create Jobs, Co-CEO Says

20 sty 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Netflix Competes for Attention Across Streaming, Broadcast, Cable, Gaming, Social Media, Video Platforms, Co-CEO Says

20 sty 2026, 22:13 UTC

Acquisitions, Mergers, Takeovers

Netflix Co-CEO: TV Landscape Has Never Been More Competitive

20 sty 2026, 22:11 UTC

Acquisitions, Mergers, Takeovers

Netflix Confident Warner Bros. Deal Would Pass Regulatory Review, Co-CEO Says

20 sty 2026, 22:10 UTC

Acquisitions, Mergers, Takeovers

Netflix Would Leverage Global Footprint, Streaming Expertise to Improve Warner Bros.'s HBO Max Service, Co-CEO Says

20 sty 2026, 22:08 UTC

Acquisitions, Mergers, Takeovers

Netflix Won't Raise Prices During Regulatory-Review Process for Pending Warner Bros. Deal, Co-CEO Says

20 sty 2026, 22:07 UTC

Acquisitions, Mergers, Takeovers

Netflix Sees Warner Bros. as Another Mechanism to Improve Offerings, Co-CEO Says

20 sty 2026, 22:06 UTC

Earnings

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- Update

20 sty 2026, 22:00 UTC

Market Talk

Acquisitions, Mergers, Takeovers

ESG Roundup: Market Talk

20 sty 2026, 21:50 UTC

Market Talk

Earnings

Tech, Media & Telecom Roundup: Market Talk

Peer Comparison

Price change

PROCEPT BioRobotics Corp Forecast

Price Target

By TipRanks

64.12% upside

12 Months Forecast

Average 49.86 USD 64.12%

High 62 USD

Low 38 USD

Based on 9 Wall Street analysts offering 12 month price targets forPROCEPT BioRobotics Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to PROCEPT BioRobotics Corp - Dist in the past 3 months.

Technical Score

By Trading Central

52.655 / 56.31Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

159 / 361 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.